[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":190900000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":-300000.0,"OtherAssetsNoncurrent_0_Q2_USD":3200000.0,"OtherAssetsCurrent_0_Q2_USD":38400000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.053,"OperatingLeaseRightOfUseAsset_0_Q2_USD":100300000.0,"OperatingLeasePayments_2_Q2_USD":5500000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":109000000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":15000000.0,"OperatingLeaseLiability_0_Q2_USD":124000000.0,"OperatingLeaseCost_2_Q2_USD":7300000.0,"OperatingIncomeLoss_2_Q2_USD":94300000.0,"OperatingIncomeLoss_1_Q2_USD":62800000.0,"NonoperatingIncomeExpense_2_Q2_USD":-9600000.0,"NonoperatingIncomeExpense_1_Q2_USD":-5300000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":-1100000.0,"NetIncomeLoss_2_Q2_USD":74400000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":190500000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-27700000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":18100000.0,"LiabilitiesCurrent_0_Q2_USD":212900000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1956400000.0,"Liabilities_0_Q2_USD":677200000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":35300000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":7100000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":17500000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":17000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":15500000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":16800000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":159300000.0,"Investments_0_Q2_USD":1264800000.0,"NetIncomeLoss_1_Q2_USD":42300000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-300000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-1100000.0,"OtherLiabilitiesCurrent_0_Q2_USD":22000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":98000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":97700000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":18200000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":3000000.0,"StockholdersEquity_0_Q2_USD":1279200000.0,"ShareBasedCompensation_2_Q2_USD":61500000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":272200000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":143200000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":21600000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":525500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":288900000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-651000000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":3200000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":371200000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":148000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":74800000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_2_Q2_USD":5000000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":29000000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":5600000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":383100000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":8800000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":2600000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":18200000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":364200000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":50000000.0,"RepaymentsOfConvertibleDebt_2_Q2_USD":100000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_1_Q2_USD":5000000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":94600000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":14200000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":11500000.0,"DebtInstrumentFaceAmount_0_Q2_USD":381200000.0,"CostsAndExpenses_2_Q2_USD":431200000.0,"CostsAndExpenses_1_Q2_USD":226100000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":6000000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":3100000.0,"ConvertibleDebtNoncurrent_0_Q2_USD":326300000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":73300000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":42000000.0,"CommonStockValue_0_Q2_USD":100000.0,"CommonStockSharesOutstanding_0_Q2_shares":94600000.0,"CommonStockSharesIssued_0_Q2_shares":94600000.0,"CommonStockSharesAuthorized_0_Q2_shares":220000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":180900000.0,"DebtInstrumentUnamortizedDiscountPremiumNet_0_Q2_USD":51500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":371200000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":2200000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":337800000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":516900000.0,"AssetsCurrent_0_Q2_USD":1110100000.0,"Assets_0_Q2_USD":1956400000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":3700000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":4700000.0,"AmortizationOfFinancingCosts_2_Q2_USD":600000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":7900000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":61500000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":28600000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1929400000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":700000.0,"AccountsReceivableNetCurrent_0_Q2_USD":158500000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":368000000.0,"DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_2_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q2_USD":516300000.0,"DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_0_Q2_USD":337900000.0,"InterestReceivableCurrent_0_Q2_USD":2700000.0,"InterestPaidNet_2_Q2_USD":4300000.0,"InterestExpense_2_Q2_USD":12600000.0,"InterestExpense_1_Q2_USD":6200000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":-5500000.0,"IncreaseDecreaseInInventories_2_Q2_USD":300000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":1400000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":29000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":10300000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":15200000.0,"IncomeTaxesPaid_2_Q2_USD":1600000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":84700000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":57500000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_2_Q2_USD":700000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q2_USD":0.0,"EquitySecuritiesFvNiRestricted_0_Q2_USD":38900000.0,"EarningsPerShareDiluted_2_Q2_USD":0.76,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":245500000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":300000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":245500000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":300000.0,"InventoryNet_0_Q2_USD":28300000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q2_security":56.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":316100000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q2_USD":3300000.0,"Depreciation_2_Q2_USD":5100000.0,"EarningsPerShareBasic_1_Q2_USD":0.45,"EarningsPerShareBasic_2_Q2_USD":0.79,"EarningsPerShareDiluted_1_Q2_USD":0.43,"DeferredFinanceCostsNet_0_Q2_USD":3400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":94400000.0,"Ticker":"NBIX","CIK":"914475","name":"NEUROCRINE BIOSCIENCES INC","OfficialName":"Neurocrine Biosciences Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"9338885763.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210803"}]